Perrigo | PRGO - Pasivo Circulante





Pasivo Circulante Cambio Fecha
AbbVie USD 41.64B 458M 2026-06
Abbott USD 18.38B 1.88B 2026-03
Bayer EUR 32.27B 1.19B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Coherus Biosciences USD 75.51M 56.82M 2026-06
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Dr.Reddys Laboratories INR 157.34B 10.13B 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
J&J USD 54.9B 2.82B 2026-06
Merck USD 27.73B 786M 2026-06
Nestle CHF 45.29B 4.6B 2026-06
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Phibro Animal Health USD 316.47M 34.6M 2026-06
Prestige Brands USD 153.81M 32.88M 2026-06
Reckitt Benckiser GBP 7.94B 901M 2024-12
Sanofi EUR 31.93B 1.92B 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06
Zoetis USD 2.06B 8M 2026-06